NEWS: India’s fincrime agency freezes Anil Ambani Group’s $351m in assets, part of ML probe

Regulatory Watch News

• 

  MONEYVAL Report on Money Laundering, Terrorist and Proliferation Financing Risks from Conflict Proceeds

  FIAU

  March 16, 2026

  The Financial Intelligence Analysis Unit (FIAU) would like to inform subject persons that the Council of Europe’s anti-money laundering and counter-terrorist financing monitoring body, MONEYVAL has published a new typologies report entitled, ‘Money Laundering, Terrorism Financing and Proliferation Financing Risks and Trends Linked to Proceeds Obtained from Conflicts’.

  This report examines how illegal proceeds which arise from regions affected by armed conflicts are laundered and used to finance terrorism and the proliferation of weapons of mass destruction. The report also identifies relevant patterns, trends and vulnerabilities with the aim of strengthening the fight against money laundering, terrorism financing, and proliferation, whilst also enhancing international co-operation.

• 

  Scam alert related to banks

  HKMA

  March 16, 2026

  The Hong Kong Monetary Authority (HKMA) wishes to alert members of the public to the press releases issued by the banks listed below relating to fraudulent websites, internet banking login screens, phishing emails or other scams, which have been reported to the HKMA.  Hyperlink to the press release is available on the HKMA website.  

  Bank	Type of Scam
  OCBC Bank (Hong Kong) Limited	Fraudulent website and internet banking login screen

   

• 

  Commission on Narcotic Drugs establishes Expert Panel to contribute to the 2029 global drug policy review

  UNODC

  March 13, 2026

  The Commission on Narcotic Drugs (CND), at its sixty-ninth session, announced today the members of the new Expert Panel established to provide recommendations for the global drug policy review to take place under the Commission in 2029. Welcoming the selection of the Expert Panel, H.E. Ambassador Andranik Hovhannisyan (Armenia), Chair of the Commission on Narcotic Drugs said: “I am confident that the collective expertise and experience represented in this Panel will contribute to informed and constructive reflections in support of the Commission’s work. The Commission looks forward with interest to the recommendations that will emerge from the Panel’s work.”